PODCAST · health
AcademicCME Podcast
by Patrick Hayes
Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice
-
57
Novel B-Cell Depleting Targeted Therapies to Improve Outcomes in Patients With Sjögren’s Disease
This activity was supported by an educational grant from Novartis. Please go to https://academiccme.com/courses/CCRSjDPod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through June 7, 2027
-
56
Improving Management of Difficult-to-Control Hypertension in Primary Care
This activity was supported by an educational grant from AstraZeneca Please go to Link and complete the evaluation to receive your CE/CME Credit. Credit is available through March 15, 2027.
-
55
Migliorare la gestione dell'ipertensione difficilmente controllabile nell'assistenza primaria
Questa attività è stata sostenuta da un contributo formativo di AstraZeneca. Si prega di visitare il Link e completare la valutazione per ricevere i crediti CE/CME. I crediti sono disponibili fino al 15 marzo 2027.
-
54
Verbesserung des Managements schwer einstellbarer Hypertonie in der Primärversorgung
Diese Veranstaltung wurde durch ein Bildungsstipendium von AstraZeneca unterstützt. Bitte rufen Sie den Link auf und füllen Sie die Evaluierung aus, um Ihre CE/CME-Punkte zu erhalten. Die Punkte sind bis zum 15. März 2027 verfügbar.
-
53
Melhoria do manejo da hipertensão de difícil controle na Atenção Primária
Esta atividade foi apoiada por um subsídio educacional da AstraZeneca. Por favor, acesse o Link e preencha a avaliação para receber seus créditos de Educação Continuada (CE/CME). Os créditos estarão disponíveis até 15 de março de 2027.
-
52
Beyond Factor Xa: FXI/XIa Inhibition and the Next Era of Stroke Prevention in Atrial Fibrillation
This activity was supported by an educational grant from the Bristol Myers Squibb and Johnson & Johnson Alliance. Please go to http://academiccme.com/HRSPod26 and complete the evaluation to receive your CE/CME Credit. Credit is available through May 6, 2027.
-
51
プライマリ・ケアにおける難治性高血圧管理の改善
本活動は、アストラゼネカ社からの教育助成により支援されました。CE/CME単位を取得するには、ACADEMICCME にアクセスし、評価を完了してください。単位の取得は、2027年3月15日まで可能です。Hon katsudō wa, asutorazeneka-sha kara no kyōiku josei ni yori shien sa remashita. CE/ CME tan'i o shutoku suru ni wa, ACADEMICCME ni akusesu shi, hyōka o kanryō shite kudasai. Tan'i no shutoku wa, 2027-nen 3 tsuki 15-nichi made kanōdesu.
-
50
Mejora del manejo de la hipertensión de difícil control en Atención primaria
Esta actividad contó con el apoyo de una subvención educativa de AstraZeneca. Por favor, acceda al enlace y complete la evaluación para recibir su crédito de educación continua (CE/CME). Los créditos estarán disponibles hasta el 15 de marzo de 2027.
-
49
Updating the Efficacy and Safety Experience of IL-17 Inhibitors
This activity was supported by an educational grant from UCB Please go to https://academiccme.com/courses/il17pod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 14, 2026.
-
48
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies
This activity was supported by an educational grant from Amgen. Please go to academiccme.com/lipidpod25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 25, 2026.
-
47
Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD
This activity was supported by an educational grant from Viatris Specialty LLC. Please go to academiccme.com/epccopdpod2 and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.
-
46
Therapeutic Update on COPD with Type 2 Inflammation
This activity was supported by an educational grant from GSK. Please go to academiccme.com/epccopd1pod and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.
-
45
Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making
This activity was supported by an educational grant from argenx. Credit is available through May 4, 2026.
-
44
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
This activity was supported by an educational grant from Vor Bio. Please go to http://academiccme.com/MG-AANEM-25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 4, 2026.
-
43
ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering
This activity was supported by an educational grant from Merck & Co., Inc. Please go to https://academiccme.com/front-matter/esc25-2/ and complete the evaluation to receive your CE/CME Credit. Credit is available through October 20, 2026.
-
42
Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)
This activity was supported by an educational grant from Bristol Myers Squibb. Please go to academiccme.com/ccrwestsle and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
-
41
Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function
This activity was supported by an educational grant from Insmed. Please go to https://academiccme.com/epcncfbepod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 7, 2026.
-
40
Conference Review and Analysis of Relevant Data Pertaining to LDL-C
This activity was supported by an educational grant from Merck & Co., Inc. Please go to https://academiccme.com/front-matter/esc25-1/ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.
-
39
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia
This activity was supported by an educational grant from Merck & Co., Inc. Please go to https://academiccme.com/front-matter/esc25-1/ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.
-
38
Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis
This activity was supported by an educational grant from EMD Serono. Please go to academiccme.com/McDonaldPod and complete the evaluation to receive your CE/CME Credit. Credit is available through October 23, 2025.
-
37
Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists
This activity was supported by an educational grant from Bristol Myers Squibb. Please go to academiccme.com/HFPod and complete the evaluation to receive your CE/CME Credit. Credit is available through May 15, 2026.
-
36
ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to http://academiccme.com/ATTRPod and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.
-
35
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
This activity was supported by an educational grant from Insmed. Please go to academiccme.com/EPCNCFBE and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
-
34
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
This activity was supported by an educational grant from Merck & Co., Inc.. Please go to academiccme.com/EPCPAH and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
-
33
Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD
This activity was supported by an educational grant from Mylan Specialty L.P., a Viatris Company. Please go to academiccme.com/front-matter/copd-podcast/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 2, 2025.
-
32
DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria
This activity was supported by an educational grant from Travere Therapeutics. Please go to https://academiccme.com/CKDCE3/ and complete the evaluation to receive your CE/CME Credit. Credit is available through November 21, 2025.
-
31
PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy
This activity was supported by an educational grant from Ipsen. Please go to academiccme.com/PBCCME and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
-
30
Clinical Trial Data Review for PBC Therapeutics
This activity was supported by an educational grant from Ipsen. Please go to academiccme.com/PBCCME and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
-
29
PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease
This activity was supported by an educational grant from Ipsen. Please go to academiccme.com/PBCCME and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
-
28
A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center
This activity was supported by an educational grant from argenx US Inc. Please go to academiccme.com/MGInfusionsCE and complete the evaluation to receive your CE/CME Credit. Credit is available through August 5, 2025.
-
27
IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment
This activity was supported by an educational grant from Travere Therapeutics. Please go to https://academiccme.com/CKDCE1/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
-
26
VTE and Anticoagulation - Guideline Updates for 2024
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE4/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
-
25
Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE3/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
-
24
Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE/ and complete the evaluation to receive your CE/CME Credit.
-
23
Part 1: Advances in Patient-Actuated Treatment for PSVT
This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.
-
22
Part 2: Advances in Patient-Actuated Treatment for PSVT
This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.
-
21
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer
Please go to academiccme.com/ovariancancer/ and complete the evaluation to receive your CE/CME Credit.
-
20
Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
-
19
Hyperkalemia 3: Clinical Trial Update for Newer Therapeutic Options to Treat Hyperkalemia
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
-
18
Hyperkalemia Part 2: Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
-
17
Hyperkalemia Part 1: Review the Science of Recurrent Hyperkalemia, Including Relationships Between Dietary Potassium Intake, Serum Potassium, and Patient Morbidities
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
-
16
Avances en el tratamiento de la ERC con inhibidores de SGLT2 en pacientes con y sin diabetes: el ensayo EMPA-KIDNEY
Vaya a https://academiccme.com/empa-kidney-es-podcast/ y complete la evaluación para recibir su crédito CE/CME.
-
15
Kombinationstherapie der chronischen Nierenerkrankung: Die EMPA-Kidney Studie
Bitte gehen Sie zu https://academiccme.com/empa-kidney-de-podcast/ und füllen Sie die Bewertung aus, um Ihren CE/CME Credit zu erhalten.
-
14
EMPA-Kidney: la révolution de la néphroprotection par les inhibiteurs SGLT-2 est là
Veuillez vous rendre sur https://academiccme.com/empa-kidney-fr-podcast/ et compléter l'évaluation pour recevoir votre crédit CE/CME.
-
13
Advances in Slowing the Progression of CKD with SGLT2 Inhibitors
Please go to https://academiccme.com/empa-kidney-podcast/ and complete the evaluation to receive your CE/CME Credit.
-
12
NTM Series Ep. 5: Evaluation of Clinical Data on NTM‐LD Therapeutics and Management
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
-
11
NTM Series Ep. 4: Diagnostic Stratgies and Long-Term Management of Patients with NTM-LD
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
-
10
NTM Series Ep. 3: Clinical Trial Update: ATS 2022
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
-
9
NTM Series Ep. 2: Improving Adherence and Outcomes While Reducing the Risk of Drug-Related Toxicity
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
-
8
NTM Series Ep. 1: Adapting Treatment Goals Based on Patient Needs
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice
HOSTED BY
Patrick Hayes
Loading similar podcasts...